UltiMed, Inc. begins manufacturing pen needles in the U.S.

  • November 11, 2011
  • Corporate News

St. Paul, MN – November 11, 2011 – UltiMed, Inc. announced the beginning of the manufacture of pen needles at its DeSmet, South Dakota facilities.

Pen needles are used on pen injectors. Pen injectors are designed for more convenient injection of insulin and other self injected medications. Pen injection is the most popular means of administrating medications in many of the world’s developed areas including Europe, Canada and Asia. Pen injection is increasing being used by self injectors in the United States.

UltiMed designed its manufacturing facility in DeSmet in anticipation of a large and rapid growth in pen needle demand. Therefore future capacity additions to UltiMed’s DeSmet pen needle production can be done rapidly and efficiently.

UltiMed, Inc., headquartered in St. Paul, Minnesota, manufactures diabetic drug delivery and specialty safety syringe devices, including insulin syringes, pen needles and specialty safety syringes for both the domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world. UltiMed, Inc. is a leader in safe needle disposal, and offers their full-line of diabetic insulin syringes and pen needles in a patented UltiGuard™ dual- use packaging style. The exclusive packaging style combines premium quality needles and an approved sharps container all in one system.

UltiMed, Inc. announces the promotion of Brahim Zabeli to Sr. Vice President

  • March 9, 2011
  • Corporate News

St. Paul, MN – March 9, 2011 – UltiMed, Inc. announced today the promotion of Brahim Zabeli to Sr. Vice President of Sales and Marketing.

Mr. Zabeli has served as the Vice President of U.S. Diabetes Care division since September 2010. In his new capacity, Zabeli will oversee all marketing and sales management programs.

UltiMed, Inc., headquartered in St. Paul, Minnesota, manufactures diabetic drug delivery and specialty safety syringe devices, including insulin syringes, pen needles and specialty safety syringes for both the domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world. UltiMed, Inc. is a leader in safe needle disposal, and offers their full-line of diabetic insulin syringes and pen needles in a patented UltiGuard™ dual- use packaging style. The exclusive packaging style combines premium quality needles and an approved sharps container all in one system.